Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News NRX Pharmaceuticals Inc NRXPW


Primary Symbol: NRXP

Financial Services Healthcare Biotechnology
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in... see more

Current News (NDAQ:NRXP)

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

GlobeNewswire 4 days ago

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

GlobeNewswire 11 days ago

NRx Builds Momentum From FDA Progress To Strategic Expansion

TheNewsWire February 27, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

GlobeNewswire February 17, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date

GlobeNewswire January 16, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

GlobeNewswire January 14, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

GlobeNewswire January 5, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

GlobeNewswire December 18, 2025

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

GlobeNewswire December 3, 2025
View More News ››

Opinion & Analysis (NDAQ:NRXP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NRXP)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - January 14, 2026

RE:RE:RE:New front runner for FDA Ketamine Approval !!!

Latest News release from PharmaTher (PHRM) and OTCNASDAQ (PHRRF)....Enjoy the read... Pharmather receives FDA approval goal date for...
Guytorule - July 4, 2025

RE:RE:New front runner for FDA Ketamine Approval !!!

Further...PharmaTher (THRM) will be disrupting the entire suppy chain for Ketamine once they get FDA approval very shortly by August 9th...
Guytorule - July 4, 2025

RE:New front runner for FDA Ketamine Approval !!!

Also listed IN U.S  on  "OTCNASDAQ"  under PHRRF....
Guytorule - July 4, 2025

New front runner for FDA Ketamine Approval !!!

Front runner and soon to become key leader to bring Ketamine to market world wide is PHARMATHER (PHRM) listed on Canadian exchange. They...
Guytorule - July 4, 2025

RE:DD for NRXP

Have you looked at PHRM?  It's along the same lines as this stock.  And it's much cheaper..
Sailormark - July 1, 2025
View more Bullboard ››

Cannabix Technologies Inc.

Cannabix Technologies Inc.

Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law ...
View More »

Podcasts